Stifel Nicolaus Has Lowered Expectations for Celsius (NASDAQ:CELH) Stock Price

Celsius (NASDAQ:CELH) had its target price decreased by investment analysts at Stifel Nicolaus from $51.00 to $45.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Stifel Nicolaus’ price target indicates a potential upside of 55.71% from the company’s current price.

A number of other equities analysts also recently commented on CELH. TD Cowen lowered their price objective on Celsius from $68.00 to $50.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th. Bank of America dropped their price objective on shares of Celsius from $32.00 to $26.00 and set an “underperform” rating on the stock in a research report on Thursday, September 5th. LADENBURG THALM/SH SH lowered their target price on shares of Celsius from $72.00 to $68.00 and set a “neutral” rating for the company in a research note on Monday, October 21st. Jefferies Financial Group cut their price target on Celsius from $53.00 to $48.00 and set a “buy” rating on the stock in a research note on Thursday, October 10th. Finally, Roth Mkm lowered their price objective on Celsius from $43.00 to $40.00 and set a “buy” rating for the company in a research report on Thursday. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Celsius currently has a consensus rating of “Moderate Buy” and a consensus target price of $54.40.

Celsius Stock Performance

Shares of CELH stock opened at $28.90 on Thursday. Celsius has a fifty-two week low of $27.78 and a fifty-two week high of $99.62. The company has a 50 day moving average price of $32.15 and a 200 day moving average price of $51.21. The stock has a market capitalization of $6.74 billion, a P/E ratio of 28.43, a price-to-earnings-growth ratio of 2.43 and a beta of 1.86.

Celsius (NASDAQ:CELH) last released its earnings results on Tuesday, August 6th. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.05. Celsius had a return on equity of 94.75% and a net margin of 19.58%. The firm had revenue of $402.00 million during the quarter, compared to analyst estimates of $391.07 million. During the same period last year, the business posted $0.17 earnings per share. Celsius’s revenue was up 23.4% compared to the same quarter last year. On average, research analysts forecast that Celsius will post 0.79 EPS for the current fiscal year.

Insider Activity

In related news, CEO John Fieldly sold 74,847 shares of the firm’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $32.80, for a total transaction of $2,454,981.60. Following the transaction, the chief executive officer now owns 1,812,490 shares of the company’s stock, valued at $59,449,672. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On Celsius

Several institutional investors have recently bought and sold shares of the company. Massachusetts Financial Services Co. MA increased its stake in shares of Celsius by 231.2% during the second quarter. Massachusetts Financial Services Co. MA now owns 3,946,208 shares of the company’s stock worth $225,289,000 after acquiring an additional 2,754,722 shares during the period. Vanguard Group Inc. raised its stake in shares of Celsius by 18.7% during the 1st quarter. Vanguard Group Inc. now owns 16,313,762 shares of the company’s stock worth $1,352,737,000 after buying an additional 2,567,290 shares in the last quarter. Capital International Investors lifted its holdings in shares of Celsius by 50.6% in the 1st quarter. Capital International Investors now owns 3,966,194 shares of the company’s stock valued at $328,877,000 after buying an additional 1,333,217 shares during the period. Capital Research Global Investors purchased a new stake in shares of Celsius in the first quarter valued at approximately $99,746,000. Finally, GQG Partners LLC acquired a new position in Celsius during the first quarter worth $76,352,000. 60.95% of the stock is owned by institutional investors and hedge funds.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.